Skip to content
MS
PAH / PTS / QDPR AR unreviewed

Phenylketonuria

Enzyme or protein defect

Phenylalanine hydroxylase (or BH4 synthesis/recycling)

Accumulates or becomes deficient

Phenylalanine; phenylketones

Key features

Intellectual disability, musty odour, hypopigmentation, eczema, seizures

Management

Phe-restricted diet, Tyr supplement, sapropterin; avoid aspartame

Not clinical guidance. Written from standard clinical biochemistry, not from the uploaded documents, and marked unreviewed. Teaching-level reference for study and database seeding only. It must not be used to manage a patient.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Engineered bacteria in disease diagnosis and therapy: A synthetic biology perspective.

    Shen Y, Lu SM, Yang L, Li Y, Zhang Y, Liang LG. · 2026-06-06

    open access unreviewed
  2. 2
    Current landscape of clinical trials for mRNA-based therapeutics.

    Li Q, Zeng M, Lv W, Ye J, Wu S. · 2026-02-23

    cited 2× open access unreviewed
  3. 3
    Probiotic extracellular vesicles reprogram macrophage immunometabolism: From gut crosstalk to host health.

    Li Y, Liu Y, Wei X, Wang C, Zahoor Khan M, Ma Q. · 2026-01-11

    cited 2× open access unreviewed
  4. 4
    Proband-independent noninvasive prenatal diagnosis for spinal muscular atrophy: early detection paving the way for early prenatal treatment.

    Li H, Gao S, Li S, Zhao Z, Fu X, Zhu J, Feng J, Tang W, Wu D, Kong X. · 2026-01-05

    open access unreviewed
  5. 5
    Living with phenylketonuria in adulthood.

    Haitjema S, Timmenga JS, Lubout CMA, Withaar FK, Wolffenbuttel BHR, van Spronsen FJ. · 2026-05-26

    unreviewed
  6. 6
    Behavioral Phenotyping of the Pah<sup>enu2</sup> Mouse Model for Phenylketonuria-A Scoping Review and Future Perspectives.

    Cao J, Kruizinga L, Hovens IB, van der Goot E, Havekes R, van der Zee EA. · 2026-09-01

    unreviewed
  7. 7
    Examining the role of social workers within clinical metabolic genetics care.

    Shim S, Cory D, Wixson G, Hata A, Werner-Lin A. · 2026-06-08

    open access unreviewed
  8. 8
  9. 9
  10. 10
    Decentralized rare disease studies in Germany: first results and hurdles of secondary use of patient data.

    Zoch M, Gierschner C, Weidner J, Sedlmayr M, Müller G, Choukair D, Hoffmann GF, Toepfner N, Berner R, Prasser… · 2026-08-12

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.